Subcutaneous nephrovesical and nephrocutaneous bypass.
OBJECTIVE
We evaluated the effectiveness of the subcutaneous bypass for ureteral obstruction in patients with advanced malignancies. Two versions of the minimally invasive technique were performed: nephrovesical and nephrocutaneous bypass.


METHODS
A specially designed composite implant consisting of an inner smooth silicone-covered tube covered by a coiled e-PTFE-tube was used in 14 patients.


RESULTS
10 subcutaneous nephrovesical bypasses were inserted in 10 patients, 8 nephrocutaneous bypasses in 4 patients. During the mean follow-up period of 13.1 months complications were observed in 2 patients with nephrocutaneous bypass, one encrustation and one infection of the bypass system.


CONCLUSIONS
The subcutaneous nephrovesical and nephrocutaneous bypass is a safe alternative for palliative treatment of ureteral obstruction caused by pelvic malignancy.
Jurczok
A
A
Department of Urology, Martin-Luther-University, Halle-Wittenberg, Germany.
Loertzer
H
H
Wagner
S
S
Fornara
P
P
D000368:Aged; D000369:Aged, 80 and over; D000714:Anastomosis, Surgical / Q000379:methods; D005260:Female; D006801:Humans; D007239:Infections; D007668:Kidney / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications; D011183:Postoperative Complications; D014517:Ureteral Obstruction / Q000209:etiology / Q000601:surgery*; D001743:Urinary Bladder / Q000601:surgery*; D014547:Urinary Diversion / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*